DNTH
Dianthus Therapeutics Inc.
96.80$
-4.3%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | +334.8% | -56.0% | +120.6% | -67.3% | |
| – | +6,166.7% | +132.7% | +110.6% | +7.3% | +2.1% | -92.7% | +141.5% | +16.1% | – | |
| – | – | – | – | – | – | +334.8% | -56.0% | +120.6% | -67.3% | |
| – | +382.5% | +48.2% | +38.8% | -15.2% | -74.1% | +133.1% | +11.8% | +153.1% | +75.2% | |
| – | +124.6% | +137.9% | +27.6% | +18.2% | -93.0% | +244.7% | +169.3% | +37.6% | +37.4% | |
| – | +281.7% | +67.1% | +37.3% | -5.4% | -81.0% | +148.1% | +41.2% | +112.0% | +66.5% | |
| – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -5.6% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | |
| – | – | +937.3% | +153.3% | +21.5% | -126.5% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.